A detailed history of Bruce G. Allen Investments, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 7 shares of MRNA stock, worth $287. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 44 84.09%
Holding current value
$287
Previous $5.23 Million 91.04%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$63.64 - $125.14 $2,354 - $4,630
-37 Reduced 84.09%
7 $468,000
Q2 2024

Jul 12, 2024

BUY
$101.21 - $166.61 $101 - $166
1 Added 2.33%
44 $5.23 Million
Q1 2024

Apr 10, 2024

BUY
$85.37 - $115.44 $1,622 - $2,193
19 Added 79.17%
43 $4.58 Million
Q4 2023

Jan 10, 2024

BUY
$69.51 - $104.43 $1,668 - $2,506
24 New
24 $2.39 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.